IL126026A0 - Novel carboxylic acid derivatives their preparation and their use - Google Patents
Novel carboxylic acid derivatives their preparation and their useInfo
- Publication number
- IL126026A0 IL126026A0 IL12602697A IL12602697A IL126026A0 IL 126026 A0 IL126026 A0 IL 126026A0 IL 12602697 A IL12602697 A IL 12602697A IL 12602697 A IL12602697 A IL 12602697A IL 126026 A0 IL126026 A0 IL 126026A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- carboxylic acid
- acid derivatives
- novel carboxylic
- novel
- Prior art date
Links
- 150000001732 carboxylic acid derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19614542A DE19614542A1 (de) | 1996-04-12 | 1996-04-12 | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| PCT/EP1997/001687 WO1997038982A1 (de) | 1996-04-12 | 1997-04-04 | Neue carbonsäurederivate, ihre herstellung und verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL126026A0 true IL126026A0 (en) | 1999-05-09 |
Family
ID=7791123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12602697A IL126026A0 (en) | 1996-04-12 | 1997-04-04 | Novel carboxylic acid derivatives their preparation and their use |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6103732A (id) |
| EP (1) | EP0892788A1 (id) |
| JP (1) | JP2000508325A (id) |
| KR (1) | KR20000005366A (id) |
| CN (1) | CN1216042A (id) |
| AR (1) | AR006593A1 (id) |
| AU (1) | AU711293B2 (id) |
| BG (1) | BG63202B1 (id) |
| BR (1) | BR9708614A (id) |
| CA (1) | CA2250764A1 (id) |
| CO (1) | CO4900038A1 (id) |
| DE (1) | DE19614542A1 (id) |
| HR (1) | HRP970200A2 (id) |
| ID (1) | ID19050A (id) |
| IL (1) | IL126026A0 (id) |
| NO (1) | NO311802B1 (id) |
| NZ (1) | NZ331704A (id) |
| PL (1) | PL329240A1 (id) |
| SK (1) | SK127698A3 (id) |
| TR (1) | TR199802042T2 (id) |
| TW (1) | TW419465B (id) |
| WO (1) | WO1997038982A1 (id) |
| ZA (1) | ZA973096B (id) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK77799A3 (en) * | 1996-12-18 | 2000-02-14 | Basf Ag | Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists |
| US6030975A (en) * | 1997-03-14 | 2000-02-29 | Basf Aktiengesellschaft | Carboxylic acid derivatives, their preparation and use in treating cancer |
| PL338954A1 (en) * | 1997-09-04 | 2000-12-04 | Basf Ag | Novel derivatives of carboxylic acids, their production and application as mixed antagonists of endothelin et a/et b receptors |
| KR100523112B1 (ko) * | 1997-10-17 | 2005-10-19 | 유로진 리미티드 | 레닌-안지오텐신계 억제제의 사용 |
| US7566452B1 (en) | 1999-05-04 | 2009-07-28 | New York University | Cancer treatment with endothelin receptor antagonists |
| PT1243262E (pt) * | 2001-03-20 | 2006-10-31 | Sanol Arznei Schwarz Gmbh | Nova utilizacao de uma classe de compostos peptideos para o tratamento da dor inflamatoria nao neuropatica |
| DK1243263T3 (da) * | 2001-03-21 | 2003-03-17 | Sanol Arznei Schwarz Gmbh | Hidtil ukendt anvendelse af en klasse af peptidforbindelser til behandling af allodyni eller andre forskellige typer af kronisk- eller fantomsmerte |
| AU2005232395B2 (en) | 2004-04-16 | 2010-09-09 | Schwarz Pharma Ag | Use of peptidic compounds for the prophylaxis and treatment of chronic headache |
| NZ552651A (en) * | 2004-08-27 | 2010-07-30 | Sanol Arznei Schwarz Gmbh | Novel use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain |
| US20070048372A1 (en) * | 2005-08-18 | 2007-03-01 | Srz Properties, Inc. | Method for treating non-inflammatory osteoarthritic pain |
| US20070043120A1 (en) * | 2005-08-18 | 2007-02-22 | Bettina Beyreuther | Therapeutic combination for painful medical conditions |
| EP1754476A1 (en) * | 2005-08-18 | 2007-02-21 | Schwarz Pharma Ag | Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia |
| CA2651679C (en) | 2006-06-15 | 2017-01-03 | Schwarz Pharma Ag | Pharmaceutical composition with synergistic anticonvulsant effect |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4411225A1 (de) * | 1994-03-31 | 1995-10-05 | Basf Ag | Verwendung von Carbonsäurederivaten als Arzneimittel |
| AU2882195A (en) * | 1994-06-27 | 1996-01-19 | Ciba-Geigy Ag | Pyrimidinyl- and triazinyl-oxy and thio-3-haloalkyl-propionic acid derivatives as herbicides |
-
1996
- 1996-04-12 DE DE19614542A patent/DE19614542A1/de not_active Withdrawn
-
1997
- 1997-04-04 TR TR1998/02042T patent/TR199802042T2/xx unknown
- 1997-04-04 US US09/155,948 patent/US6103732A/en not_active Expired - Fee Related
- 1997-04-04 WO PCT/EP1997/001687 patent/WO1997038982A1/de not_active Application Discontinuation
- 1997-04-04 CA CA002250764A patent/CA2250764A1/en not_active Abandoned
- 1997-04-04 EP EP97918109A patent/EP0892788A1/de not_active Withdrawn
- 1997-04-04 PL PL97329240A patent/PL329240A1/xx unknown
- 1997-04-04 SK SK1276-98A patent/SK127698A3/sk unknown
- 1997-04-04 NZ NZ331704A patent/NZ331704A/en unknown
- 1997-04-04 CN CN97193737A patent/CN1216042A/zh active Pending
- 1997-04-04 KR KR1019980708088A patent/KR20000005366A/ko not_active Application Discontinuation
- 1997-04-04 IL IL12602697A patent/IL126026A0/xx unknown
- 1997-04-04 AU AU26364/97A patent/AU711293B2/en not_active Ceased
- 1997-04-04 JP JP9536698A patent/JP2000508325A/ja active Pending
- 1997-04-04 BR BR9708614A patent/BR9708614A/pt not_active IP Right Cessation
- 1997-04-10 AR ARP970101432A patent/AR006593A1/es not_active Application Discontinuation
- 1997-04-11 CO CO97018895A patent/CO4900038A1/es unknown
- 1997-04-11 HR HR19614542.2A patent/HRP970200A2/xx not_active Application Discontinuation
- 1997-04-11 ZA ZA973096A patent/ZA973096B/xx unknown
- 1997-04-11 TW TW086104674A patent/TW419465B/zh not_active IP Right Cessation
- 1997-04-14 ID IDP971240A patent/ID19050A/id unknown
-
1998
- 1998-09-15 BG BG102770A patent/BG63202B1/bg unknown
- 1998-10-09 NO NO19984713A patent/NO311802B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TR199802042T2 (xx) | 2000-09-21 |
| JP2000508325A (ja) | 2000-07-04 |
| HRP970200A2 (en) | 1998-04-30 |
| EP0892788A1 (de) | 1999-01-27 |
| PL329240A1 (en) | 1999-03-15 |
| AU711293B2 (en) | 1999-10-07 |
| DE19614542A1 (de) | 1997-10-16 |
| NZ331704A (en) | 2000-06-23 |
| CA2250764A1 (en) | 1997-10-23 |
| TW419465B (en) | 2001-01-21 |
| BG63202B1 (bg) | 2001-06-29 |
| ZA973096B (en) | 1998-10-12 |
| BR9708614A (pt) | 1999-08-03 |
| AU2636497A (en) | 1997-11-07 |
| ID19050A (id) | 1998-06-04 |
| KR20000005366A (ko) | 2000-01-25 |
| CO4900038A1 (es) | 2000-03-27 |
| AR006593A1 (es) | 1999-09-08 |
| SK127698A3 (en) | 2000-03-13 |
| WO1997038982A1 (de) | 1997-10-23 |
| CN1216042A (zh) | 1999-05-05 |
| NO311802B1 (no) | 2002-01-28 |
| NO984713L (no) | 1998-10-09 |
| NO984713D0 (no) | 1998-10-09 |
| US6103732A (en) | 2000-08-15 |
| BG102770A (en) | 1999-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA979175B (en) | Novel piperidineketocarboxylic acid derivatives their preparation and use | |
| EP1024130A4 (en) | BIPHENYL-5-ALKANIC ACID DERIVATIVES AND THEIR USE | |
| PL331861A1 (en) | Derivatives of propionic acid and their application | |
| PL338357A1 (en) | Some 5-alkyl-2-arylaminophenyloacetic acids and their derivatives | |
| IL116325A0 (en) | Substituted 1h-imidazoles their preparation and use | |
| IL120124A0 (en) | Heteroaryl-oxazolidinones their preparation and use | |
| ZA977946B (en) | Novel carboxylic acid derivatives their preparation and use as mixed etalpha/etbeta receptor atagonists | |
| ZA973097B (en) | Novel aspire-hydroxy acid derivatives their preparation and use | |
| HUP9902645A3 (en) | Fused-ring carboxylic acid derivatives | |
| IL123611A0 (en) | Novel amino acid derivatives their preparation and use | |
| AU4161797A (en) | Benzoperimidine-carboxylic acids and derivatives thereof | |
| ZA973098B (en) | Novel carboxylic acid derivatives their preparation and use | |
| ZA973096B (en) | Novel carboxylic acid derivatives their preparation and use | |
| IL128096A0 (en) | Arylcycloalkane carboxylic esters their use pharmaceutical compositions and preparation | |
| AU5836498A (en) | N-acyl-hydroxyamino acid esters and their use | |
| HUP0000084A3 (en) | 3-alkoxyisoxazol-4-yl-substituted-2-amino carboxylic acid derivatives, their use and pharmaceutical compositions containing them | |
| PL331263A1 (en) | Derivatives of glyoxylic acid | |
| IL131666A0 (en) | Novel carboxylic acid derivatives their preparation and use in treating cancer | |
| AU3695297A (en) | Alfa-amino acid amides, preparation thereof and the therapeutical use thereof | |
| AU6120298A (en) | 2-peperazinone-1-acetic acid derivatives and their use | |
| GR3034797T3 (en) | Carboxylic acid derivatives, their preparation and their use | |
| IL115183A0 (en) | Imidic acid derivatives their preparation and use | |
| IL120903A0 (en) | Fluoroalkylglycosiduronic acids and corresponding 6(3)-lactones their preparation and their uses | |
| IL119306A0 (en) | 2-(4-pyrazolyloxy-pyrimidin-5-yl) acetic acid derivatives and their preparation | |
| IL116134A0 (en) | Iminooxybenzylcrotonate esters their preparation and their use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HP | Change in proprietorship |